Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
With
Daiichi Sankyo
The reference formulation is an orally disintegrating tablet without Magnasweet® (ODT1) and the test formulation is an orally disintegrating tablet containing Magnasweet® (ODT2).
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Body mass index (BMI) of 18.5 to 32.0 kilograms per square meter (kg/m\^2)
You may not be if
No known allergies to Prasugrel or related compound
No regular alcohol intake greater than 21 units per week for males or 14 units per week for females
Clareo Health | A Study of Prasugrel in Healthy Participants
